CD8A and cancer: IL-15 is a crucial cytokine for the development, maturation, and activation of NK cells and CD8+ T cells, with no effect on the expansion of the T regulatory cell population involved in suppressing immune responses, and thus has a potential therapeutic use in cancer immunotherapy (20, 40, 41).